A trial comparing gemcitabine and vandetanib with gemcitabine alone in pancreatic cancer (ViP)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Pancreatic cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is comparing gemcitabine and vandetanib to gemcitabine alone for people with pancreatic cancer. This trial is supported by Cancer Research UK.

Recruitment start: 10 October 2011

Recruitment end: 23 October 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Gary Middleton

Supported by

AstraZeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Liverpool Cancer Trials Unit

NIHR Clinical Research Network: Cancer

Royal Liverpool and Broadgreen University Hospital NHS Trust

University of Liverpool

Other information

This is Cancer Research UK trial number CRUKE/10/025.

Last reviewed: 11 Aug 2016

CRUK internal database number: 6193

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.